Protein A sepharose immunoadsorption: Immunological and haemostatic effects in two cases of acquired haemophilia

British Journal of Haematology

Volumn 114, Issue 4, 2001, Pages 837-844

  Guillet, B ^a   Kriaa, F ^a   Huysse, M G ^a   Proulle, V ^a   George, C ^a   Tchernia, G ^a   D'Oiron, R ^a   Laurian, Y ^a   Charpentier, B ^a   Lambert, T ^a   Dreyfus, M ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Acquired haemophilia; Anti FVIII:C inhibitor; Immunoadsorption on protein A sepharose

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; PREDNISOLONE; PROTEIN A; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SEPHAROSE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; ERYTHROCYTE; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HEMOPHILIA; HEMOSTASIS; HUMAN; IMMUNOADSORPTION; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PATHOGENESIS; PERITONITIS; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ADULT; BLOOD LOSS, SURGICAL; FACTOR VIIA; HEMOPHILIA A; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PLASMAPHERESIS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL PROTEIN A;

EID: 0034799599     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03022.x     Document Type: Article

References (38)

1. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor
2. Acquired inhibitors
3. Plasma exchange in non-haemophiliac patients with inhibitors to factor VIII
4. Plasmapheresis: Its value in the management of patients with antibodies to factor VIII
5. Clinical and immunologic effects of staphylococcal protein A immunoadsorption therapy for inhibitor to factor VIII
6. Therapeutic protein A immunoadsorption: A review
7. Kinetic aspects of the removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption
8. Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide
9. A survey of 215 non-hemophilic patients with inhibitors to factor VIII
10. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies
11. Plasmapheresis and factor VIII inhibitors
12. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment
13. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multi-centre study
14. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone
15. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)
16. A more uniform measurement of factor VIII inhibitors
17. The treatment of acquired factor VIII inhibitors: Worldwide experience with porcine factor VIII concentrate
18. Extracorporeal immunoadsorption for congenital FXI deficiency with FXI inhibitor undergoing liver transplantation
19. Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb)
20. Five years experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis
21. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor
22. Thrombogenicity associated with factor IX complex concentrates
23. Use of factor VIII bypassing agents to control bleeding in patients with acquired factor VIII inhibitors
24. Hazards of prothrombin complex concentrates in treatment of hemophilia
25. A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: Substitution therapy and surgery in a patient with hemophilia B and antibodies
26. Extracorporeal protein A-sepharose and specific affinity chromatography for removal of antibodies
27. Acquired factor VIII inhibitor in a non-hemophiliac patient: Successful treatment with plasma exchange associated with factor VIII concentrate and immunosuppressors
28. Acute myocardial infarction following administration of recombinant activated factor VII (Novoseven) in a patient with haemophilia A and inhibitor
29. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor
30. Recombinant activated factor VII (Novoseven) treatment of platelet-related bleeding disorders
31. A prospective study of treatment of acquired factor VIII inhibitors with high dose intravenous immunoglobulin
32. Acquired inhibitors to the blood coagulation factors
33. The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII
34. Corticosteroid therapy for acquired factor VIII inhibitors
35. Successful management of a patient with acquired factor VIII inhibitor
36. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII inhibitors
37. Extracorporeal immunoadsorption: An alternative treatment for hemophiliacs with high-responding inhibitors
38. Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: A review of US clinical studies 1987-90